Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration.

Schmidt B, Ashlock BM, Foster H, Fujimura SH, Levy JA.

Virology. 2005 Dec 20;343(2):256-66. Epub 2005 Nov 8.

2.
3.

Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation.

Schmidt B, Scott I, Whitmore RG, Foster H, Fujimura S, Schmitz J, Levy JA.

Virology. 2004 Nov 24;329(2):280-8.

4.

Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.

Cavaleiro R, Baptista AP, Soares RS, Tendeiro R, Foxall RB, Gomes P, Victorino RM, Sousa AE.

PLoS Pathog. 2009 Nov;5(11):e1000667. doi: 10.1371/journal.ppat.1000667. Epub 2009 Nov 20.

5.

Role for plasmacytoid dendritic cells in anti-HIV innate immunity.

Müller-Trutwin M, Hosmalin A.

Immunol Cell Biol. 2005 Oct;83(5):578-83. Review.

PMID:
16174110
6.

CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells.

Pritschet K, Donhauser N, Schuster P, Ries M, Haupt S, Kittan NA, Korn K, Pöhlmann S, Holland G, Bannert N, Bogner E, Schmidt B.

Virology. 2012 Feb 20;423(2):152-64. doi: 10.1016/j.virol.2011.11.026. Epub 2011 Dec 29.

7.

Type I interferon-dependent gene MxA in perinatal HIV-infected patients under antiretroviral therapy as marker for therapy failure and blood plasmacytoid dendritic cells depletion.

Badolato R, Ghidini C, Facchetti F, Serana F, Sottini A, Chiarini M, Spinelli E, Lonardi S, Plebani A, Caimi L, Imberti L.

J Transl Med. 2008 Sep 9;6:49. doi: 10.1186/1479-5876-6-49.

8.

Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.

Killian MS, Fujimura SH, Hecht FM, Levy JA.

AIDS. 2006 Jun 12;20(9):1247-52.

PMID:
16816552
9.

Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment.

Chehimi J, Azzoni L, Farabaugh M, Creer SA, Tomescu C, Hancock A, Mackiewicz A, D'Alessandro L, Ghanekar S, Foulkes AS, Mounzer K, Kostman J, Montaner LJ.

J Immunol. 2007 Aug 15;179(4):2642-50.

10.

Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon.

Jaehn PS, Zaenker KS, Schmitz J, Dzionek A.

Eur J Immunol. 2008 Jul;38(7):1822-32. doi: 10.1002/eji.200737552.

11.

Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients.

Lehmann C, Harper JM, Taubert D, Hartmann P, Fätkenheuer G, Jung N, van Lunzen J, Stellbrink HJ, Gallo RC, Romerio F.

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):522-30. doi: 10.1097/QAI.0b013e31817f97cf.

PMID:
18645522
12.

Plasmacytoid dendritic cells migrate in afferent skin lymph.

Pascale F, Contreras V, Bonneau M, Courbet A, Chilmonczyk S, Bevilacqua C, Epardaud M, Niborski V, Riffault S, Balazuc AM, Foulon E, Guzylack-Piriou L, Riteau B, Hope J, Bertho N, Charley B, Schwartz-Cornil I.

J Immunol. 2008 May 1;180(9):5963-72. Erratum in: J Immunol. 2008 Jun 15;180(12):8470. Pascale, Florentia [corrected to Pascale, Florentina]; Eparaud, Mathieu [corrected to Epardaud, Mathieu].

13.

CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection.

Ferbas JJ, Toso JF, Logar AJ, Navratil JS, Rinaldo CR Jr.

J Immunol. 1994 May 1;152(9):4649-62. Erratum in: J Immunol 1994 Jul 15;153(2):910.

PMID:
7908920
14.

Type I interferon production in HIV-infected patients.

Hosmalin A, Lebon P.

J Leukoc Biol. 2006 Nov;80(5):984-93. Epub 2006 Aug 17. Review.

PMID:
16916960
15.

Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors.

Feldman S, Stein D, Amrute S, Denny T, Garcia Z, Kloser P, Sun Y, Megjugorac N, Fitzgerald-Bocarsly P.

Clin Immunol. 2001 Nov;101(2):201-10.

PMID:
11683579
16.

Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production.

Fanning SL, George TC, Feng D, Feldman SB, Megjugorac NJ, Izaguirre AG, Fitzgerald-Bocarsly P.

J Immunol. 2006 Nov 1;177(9):5829-39.

17.

Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?

Herbeuval JP, Shearer GM.

AIDS Rev. 2006 Jan-Mar;8(1):3-8. Review.

PMID:
16736946
18.
19.

Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells.

Audigé A, Urosevic M, Schlaepfer E, Walker R, Powell D, Hallenberger S, Joller H, Simon HU, Dummer R, Speck RF.

J Immunol. 2006 Nov 1;177(9):6227-37.

20.

Image-based study of interferongenic interactions between plasmacytoid dendritic cells and HSV-infected monocyte-derived dendritic cells.

Megjugorac NJ, Jacobs ES, Izaguirre AG, George TC, Gupta G, Fitzgerald-Bocarsly P.

Immunol Invest. 2007;36(5-6):739-61.

PMID:
18161527

Supplemental Content

Support Center